Literature DB >> 12399509

Structural heterogeneity of the streptococcal C5a peptidase gene in Streptococcus pyogenes.

Irina V Koroleva1, Androulla Efstratiou, Alexander N Suvorov.   

Abstract

The 3' ends of the genes for the C-terminal region of C5a peptidase from 15 Streptococcus pyogenes isolates were analyzed by PCR. Amplicons were found to differ in size. DNA sequence analysis revealed that the differences between PCR fragment sizes accorded with the number of R repeats in the C5a peptidase gene.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12399509      PMCID： PMC151962          DOI： 10.1128/JB.184.22.6384-6386.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  19 in total

Review 1.  Recent advances in the polymerase chain reaction.

Authors:  H A Erlich; D Gelfand; J J Sninsky
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci.

Authors:  P P Cleary; J Peterson; C Chen; C Nelson
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 3.  PEST sequences are signals for rapid intracellular proteolysis.

Authors:  M Rechsteiner
Journal:  Semin Cell Biol       Date:  1990-12

4.  Purification of the proteinase from group B streptococci that inactivates human C5a.

Authors:  J F Bohnsack; X N Zhou; P A Williams; P P Cleary; C J Parker; H R Hill
Journal:  Biochim Biophys Acta       Date:  1991-08-30

5.  Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.

Authors:  J F Bohnsack; K W Mollison; A M Buko; J C Ashworth; H R Hill
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

6.  In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants.

Authors:  S P O'Connor; P P Cleary
Journal:  J Infect Dis       Date:  1987-09       Impact factor: 5.226

7.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

8.  Similarity between the group B and A streptococcal C5a peptidase genes.

Authors:  P P Cleary; J Handley; A N Suvorov; A Podbielski; P Ferrieri
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

9.  Streptococcal C5a peptidase is a highly specific endopeptidase.

Authors:  P P Cleary; U Prahbu; J B Dale; D E Wexler; J Handley
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.

Authors:  Y Ji; L McLandsborough; A Kondagunta; P P Cleary
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441
View more
  4 in total

1.  Genetics of streptococci, lactococci, and enterococci: review of the sixth international conference.

Authors:  Janet Yother; Patrick Trieu-Cuot; Todd R Klaenhammer; Willem M De Vos
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

Review 2.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides.

Authors:  Yulia A Desheva; Galina F Leontieva; Tatiana A Kramskaya; Tatiana A Smolonogina; Kornelia B Grabovskaya; Irina V Kiseleva; Larisa G Rudenko; Alexander N Suvorov
Journal:  Open Microbiol J       Date:  2016-10-31

4.  Development of experimental GBS vaccine for mucosal immunization.

Authors:  T Gupalova; G Leontieva; T Kramskaya; K Grabovskaya; E Bormotova; D Korjevski; A Suvorov
Journal:  PLoS One       Date:  2018-05-04       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.